Q3 2025 Holdings
Filed 2025-11-13 | 58 holdings | $123.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $23.6M | 2,670,032 | 19.2% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $10.8M | 739,000 | 8.8% |
| Evolus Inc(EOLS) | COM | 30052C107 | $9.4M | 1,536,391 | 7.7% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $7.7M | 810,000 | 6.3% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $4.8M | 85,000 | 3.9% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $4.6M | 647,382 | 3.7% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $4.4M | 115,459 | 3.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $3.7M | 174,544 | 3.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $3.7M | 305,000 | 3.0% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $3.6M | 1,056,338 | 2.9% |
| Omniab Inc(OABI) | COM | 68218J103 | $3.4M | 2,142,857 | 2.8% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $3.2M | 250,146 | 2.6% |
| Tela BIO Inc(TELA) | COM | 872381108 | $3.2M | 2,155,519 | 2.6% |
| Indivior PLC(INDV) | ORD | G4766E116 | $2.4M | 100,000 | 2.0% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $2.4M | 450,970 | 1.9% |
| Geron Corp(GERN) | COM | 374163103 | $2.2M | 1,600,000 | 1.8% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $1.9M | 1,370,139 | 1.6% |
| Edesa Biotech Inc(EDSA) | COM NEW | 27966L306 | $1.7M | 687,500 | 1.4% |
| Aytu Biopharma Inc(AYTU) | COM | 054754858 | $1.7M | 891,855 | 1.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $1.6M | 24,000 | 1.3% |
| Kezar Life Sciences Inc(KZR) | COM NEW | 49372L209 | $1.5M | 383,182 | 1.2% |
| Alumis Inc(ALMS) | COM | 022307102 | $1.2M | 300,000 | 1.0% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $1.2M | 735,019 | 1.0% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $1.1M | 188,571 | 0.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.1M | 200,000 | 0.9% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $1.1M | 670,000 | 0.9% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $1.1M | 108,094 | 0.9% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $1.1M | 850,100 | 0.9% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $973.1K | 195,000 | 0.8% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $913.6K | 160,000 | 0.7% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $846.1K | 157,569 | 0.7% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $725.2K | 459,018 | 0.6% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $716.2K | 563,913 | 0.6% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $685.2K | 453,800 | 0.6% |
| Angiodynamics Inc(ANGO) | COM | 03475V101 | $670.2K | 60,000 | 0.5% |
| Grace Therapeutics Inc(GRCE) | COM | 00439U104 | $628.2K | 211,010 | 0.5% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $601.6K | 20,000 | 0.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $572.3K | 37,200 | 0.5% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $562.4K | 100,600 | 0.5% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $538.5K | 204,770 | 0.4% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $508.5K | 413,453 | 0.4% |
| Health Catalyst Inc(HCAT) | COM | 42225T107 | $443.3K | 155,551 | 0.4% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $433.9K | 10,585 | 0.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $428.1K | 289,237 | 0.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $398.8K | 125,000 | 0.3% |
| Kiora Pharmaceuticals Inc(KPRX) | COM | 49721T507 | $390.9K | 140,598 | 0.3% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $376.0K | 40,000 | 0.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $366.5K | 192,900 | 0.3% |
| In8bio Inc(INAB) | COM NEW | 45674E208 | $345.9K | 159,421 | 0.3% |
| Helius MED Technologies Inc(HSDT) | COM CL A NEW | 42328V876 | $297.8K | 20,000 | 0.2% |